Dialpha

Dialpha is a French biotechnology company and specialized Contract Research Organization (CRO) focused on metabolic health and nutrition. The company provides a comprehensive suite of preclinical and clinical services to evaluate the efficacy of pharmaceutical compounds, food supplements, and functional ingredients. Their expertise primarily lies in glucose and lipid metabolism, with a particular focus on controlling post-prandial glycemic responses to manage type 2 diabetes and obesity. In addition to its CRO services, Dialpha develops proprietary bioactive ingredients designed to improve metabolic parameters. Based in Grabels, France, the company serves as a strategic partner for both the life science and food industries in validating health claims and therapeutic efficacy.